Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1

Conditions

Melanoma 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 289Magnetic Resonance Spectroscopy 240pembrolizumab 223Carboplatin 183Biopsy 154Cyclophosphamide 148Cisplatin 145Paclitaxel 129Nivolumab 124Gemcitabine 114Bevacizumab 110Radiotherapy 87Dexamethasone 85Pemetrexed 81atezolizumab 78fludarabine 76Fluorouracil 75Doxorubicin 74Docetaxel 72Leucovorin 69Rituximab 68Radiation 68Oxaliplatin 66Prednisone 65venetoclax 64durvalumab 60Vincristine 59Cetuximab 56130-nm albumin-bound paclitaxel 56Immunoglobulin G 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ketones × 30 days × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡